Living Successfully with Multiple Myeloma
October 19, 2019
Little Rock Marriott
3 Statehouse Plaza | Little Rock, AR
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
We are committed to
- Accelerating curative therapies for multiple myeloma and related diseases through an integrated program of innovative research and high-quality, comprehensive patient care
- Customizing care based on each patient’s genetic profile and risk factors for truly personalized treatment
- Pushing the envelope of understanding and discovery to unravel the biology of multiple myeloma and maximize cure
Meet the Myeloma Center in August with Carolina Schinke
Little Rock Volunteer Uses Love of Knitting to Give to UAMS Cancer PatientsSeptember 23, 2019
Carolaina Ferren uses her knitting needles, crochet hooks, and bundles of yarn to share her empathy with those who are battling cancer.
Michael Birrer, M.D., Ph.D., Named UAMS Winthrop P. Rockefeller Cancer Institute DirectorSeptember 13, 2019
Internationally recognized medical oncologist Michael Birrer, M.D., Ph.D., has been named vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). Birrer specializes in gynecologic cancers and will join the university by the end of the year.
Woman Resumes Humanitarian Trips to China after Myeloma TreatmentAugust 22, 2019
Cindy Sites loves sharing the gift of music with others. Whenever she visits the Myeloma Center in the UAMS Winthrop P. Rockefeller Cancer Institute, she likes playing the Steinway grand piano in the lobby.